/NNLX

NNLX Stock - NanoLogix, Inc.

Q: What is the analyst price target for NNLX?

Analyst price target information is not currently available for NNLX.

Q: What is NNLX's market cap?

Market capitalization information is not currently available for NNLX.

Healthcare|Biotechnology|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NNLX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2009

FY2010

FY2011

FY2012

FY2013

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-34.75

52W High$0.04

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2013	FY2012	FY2011	FY2010	FY2009
Revenue	$35,598	$88,334	$892	$640	$21,361
Gross Profit	$-710,044	$-858,417	$-927,188	N/A	N/A
Gross Margin	-1994.6%	-971.8%	-103944.8%	0.0%	0.0%
Operating Income	$-1,297,979	$-1,763,091	$-1,860,098	$-2,647,174	$-1,073,260
Net Income	$-1,292,639	$-1,746,596	$-1,860,879	$-2,655,784	$-1,160,075
Net Margin	-3631.2%	-1977.3%	-208618.7%	-414966.3%	-5430.8%
EPS	$-0.01	$-0.01	$-0.02	$-0.02	$-0.01

Company Overview

NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company's products include BioNanoPore kit, which employs a water permeable membrane that works with organic and inorganic molecules, as well as proteins; and FlatPack Petri Plates that are used for the isolation and cultivation of various fastidious and non-fastidious microorganisms, as well as displays growth of aerobic and anaerobic microorganisms. Its products are used in medical, national defense, homeland security, pharmaceutical, industrial, veterinary, and environmental testing applications. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. NanoLogix, Inc. is based in Hubbard, Ohio.

Visit Website